News

NZCR Lead Research Physician Dr Alexandra Cole, CEO Dr Christian Schwabe and Business Development Manager, Marcus Burrows are pleased to be representing NZCR at ARCS 2022 in Sydney this week.

New Zealand Clinical Research (NZCR) is putting put out a call for healthy males in Auckland and Christchurch to be part of two large trials researching potential new treatments for breast cancer.

A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab
biosimilar, in healthy adult subjects

NZCR is reducing medical waste and helping the Pacific Islands at the same time

NZCR staff received a lovely surprise this week.

Alvotech receives EU approval for AVT02

NZCR Supports Covid -19 Vaccination for all New Zealanders.

Lipid and Diabetes Research Group joins the NZCR research family

Drs Christian Schwabe and Dr Chris Wynne are authors of a recent Bevacizumab biosimilar publication.

NZCR CEO receives IQVIA Certificate of Achievement (2020)

Kiwis are being given an opportunity to take part in a trial of a potential new COVID-19 vaccine.

New Zealand is leading the world in a new era of exciting gene research with potential to cure genetic conditions in the future.